Vitamin D and Gestational Diabetes
Gestational diabetes mellitus (GDM) affects 6–10% of pregnancies and increases short-term (macrosomia, preeclampsia) and long-term (maternal type 2 diabetes, offspring metabolic) risk. Vitamin D deficiency is common in pregnancy and has been examined as both a risk factor and a therapeutic target.
Deficiency and GDM risk
A 2018 meta-analysis of 26 observational studies (Amraei) found women with 25(OH)D < 20 ng/mL in early pregnancy had ~40% higher odds of developing GDM than sufficient women. Mendelian randomisation analyses are mixed on causation, but the association is consistent.
Supplementation trials
- Asemi 2013 — 54 women with GDM; 50,000 IU vitamin D + 1,000 mg calcium × 3 doses reduced fasting glucose and insulin resistance vs placebo.
- DALI trial (2016) — 154 obese pregnant women; 1,600 IU/day + lifestyle intervention did not reduce GDM incidence vs placebo.
- Rodrigues 2019 meta-analysis — 20 RCTs; vitamin D supplementation modestly reduced fasting glucose, insulin, HOMA-IR in women with GDM, but did not prevent GDM.
Postpartum considerations
GDM in one pregnancy carries roughly 40–60% lifetime risk of type 2 diabetes for the mother. Sustained vitamin D adequacy is one modifiable factor in that trajectory. See our diabetes page for the T2D prevention evidence (D2d trial and others).
Practical guide
- Preconception and early pregnancy: test 25(OH)D; correct deficiency to ≥ 30 ng/mL.
- Standard prenatal vitamin (typically 400–600 IU cholecalciferol) may not be enough — many pregnant women need an additional 1,000–2,000 IU/day.
- GDM diagnosis: continue vitamin D supplementation alongside medical nutrition therapy, glucose monitoring, and (if needed) metformin or insulin.
- Postpartum: continue supplementation, especially while breastfeeding — see pregnancy page for maternal doses that transfer to breastmilk.
- Post-GDM follow-up: screen for T2D at 6–12 weeks postpartum and every 1–3 years thereafter.